{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:20:21Z","timestamp":1778772021339,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:00:00Z","timestamp":1537574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Hebei Science and Technology Agency","award":["172777190"],"award-info":[{"award-number":["172777190"]}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.radonc.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T22:07:18Z","timestamp":1538086038000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma"],"prefix":"10.1016","volume":"129","author":[{"given":"Xuejiao","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.09.006_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2018.09.006_b0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2018.09.006_b0015","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/djp304","article-title":"Re: incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age","volume":"101","author":"Chien","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2018.09.006_b0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-5223(95)70428-0","article-title":"Carcinoma of the esophagus. Prognostic significance of histologic type","volume":"109","author":"Lieberman","year":"1995","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2018.09.006_b0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semradonc.2006.09.007","article-title":"Are squamous and adenocarcinomas of the esophagus the same disease?","volume":"17","author":"Siewert","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0030","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1016\/j.ijrobp.2011.06.531","article-title":"Definitive concurrent chemotherapy and high-dose (60\u201370\u202fGy) radiotherapy for esophageal cancer","volume":"81","author":"Hayashi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.006_b0035","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1016\/j.ijrobp.2015.07.882","article-title":"Definitive concurrent chemotherapy and high dose (60\u201370\u202fGy) radiation therapy for esophageal cancer","volume":"93","author":"Kondo","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.006_b0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ijrobp.2016.08.016","article-title":"Radiation dose escalation in esophageal cancer revisited: a contemporary analysis of the national cancer data base, 2004 to 2012","volume":"96","author":"Brower","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.006_b0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94\u201305) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0050","first-page":"1263","article-title":"Optimal radiation dose for esophageal squamous cell carcinoma","volume":"26","author":"Wang","year":"2017","journal-title":"Chin J Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0055","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jjco\/hyu047","article-title":"High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II\u2013III esophageal cancer","volume":"44","author":"Suh","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0060","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-717X-7-60","article-title":"Treatment strategies for oesophageal cancer \u2013 time-trends and long term outcome data from a large tertiary referral centre","volume":"7","author":"Wolf","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1442-2050.2011.01286.x","article-title":"Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer","volume":"25","author":"Semrau","year":"2012","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.radonc.2018.09.006_b0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3748\/wjg.v23.i3.540","article-title":"Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma","volume":"23","author":"Zhu","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.radonc.2018.09.006_b0075","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1586\/14737140.2015.1074041","article-title":"High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis","volume":"15","author":"Song","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.radonc.2018.09.006_b0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2016.04.042","article-title":"Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis","volume":"120","author":"Chen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.radonc.2017.08.025","article-title":"Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma","volume":"125","author":"Chang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4251\/wjgo.v6.i8.263","article-title":"Esophageal cancer management controversies: radiation oncology point of view","volume":"6","author":"Tai","year":"2014","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0095","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2015.07.2284","article-title":"Radiation therapy intensification for solid tumors: a systematic review of randomized trials","volume":"93","author":"Yamoah","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.006_b0100","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1245\/s10434-009-0401-0","article-title":"Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy","volume":"16","author":"Hsu","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1748-717X-8-33","article-title":"Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction","volume":"8","author":"Yaremko","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2011.12.041","article-title":"Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study","volume":"84","author":"Nicolini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.006_b0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2004.03.004","article-title":"Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy","volume":"71","author":"Wu","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0120","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0125","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","article-title":"Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus","volume":"21","author":"Ishikura","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0130","first-page":"512","article-title":"Different radiation treatment in esophageal carcinoma: a clinical comparative study","volume":"17","author":"Li","year":"2012","journal-title":"J BUON"},{"issue":"17","key":"10.1016\/j.radonc.2018.09.006_b0135","first-page":"32682","article-title":"With or without consolidation chemotherapy using cisplatin\/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: a propensity score-matched analysis","volume":"S0167\u20138140","author":"Chen","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2016.10.021","article-title":"The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy","volume":"121","author":"Wang","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0145","doi-asserted-by":"crossref","first-page":"3432750","DOI":"10.1155\/2017\/3432750","article-title":"Oral Chinese herbal medicine as an adjuvant treatment for chemotherapy, or radiotherapy, induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials","volume":"2017","author":"Hou","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.radonc.2018.09.006_b0150","doi-asserted-by":"crossref","first-page":"46524","DOI":"10.1038\/srep46524","article-title":"Effects of Chinese medicine as adjunct medication for adjuvant chemotherapy treatments of non-small cell lung cancer patients","volume":"7","author":"Jiao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2018.09.006_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/690976","article-title":"Chinese herbal medicine for myelosuppression induced by chemotherapy or radiotherapy: a systematic review of randomized controlled trials","volume":"2015","author":"Jia","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.radonc.2018.09.006_b0160","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/736197","article-title":"Effects of traditional chinese medicine on chemotherapy-induced myelosuppression and febrile neutropenia in breast cancer patients","volume":"2015","author":"Tian","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.radonc.2018.09.006_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/1759-7714.12536","article-title":"Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: experience of two centers","volume":"9","author":"Chen","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.radonc.2018.09.006_b0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/sajc.sajc_178_17","article-title":"Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: a prospective randomized study","volume":"7","author":"Nayan","year":"2018","journal-title":"South Asian J Cancer"},{"key":"10.1016\/j.radonc.2018.09.006_b0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.adro.2017.04.002","article-title":"Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: a large single-institutional cohort study","volume":"2","author":"Shi","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.09.006_b0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jtho.2016.10.013","article-title":"Local control and toxicity of a simultaneous integrated boost for dose escalation in locally advanced esophageal cancer: interim results from a prospective Phase I\/II trial","volume":"12","author":"Welsh","year":"2017","journal-title":"J Thorac Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018334893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018334893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:47:57Z","timestamp":1571964477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018334893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0167814018334893"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}